Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Banco de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Pract Neurol ; 24(1): 60-62, 2024 Jan 23.
Artículo en Inglés | MEDLINE | ID: mdl-37845038

RESUMEN

A 69-year-old woman developed non-convulsive status epilepticus during inpatient investigation for abdominal pain. Initial detailed investigations did not identify the cause of seizures, but a jejunal biopsy and PCR testing in various fluids led to the diagnosis of Whipple's disease with neurological involvement. The seizures were controlled but she subsequently had moderate cognitive impairment. Whipple's disease is an important diagnosis, being treatable with antibiotics. Testing for Whipple's disease is not part of the recommended workup in for status epilepticus, but this case highlights the importance of considering this condition.


Asunto(s)
Estado Epiléptico , Enfermedad de Whipple , Femenino , Humanos , Anciano , Enfermedad de Whipple/complicaciones , Enfermedad de Whipple/diagnóstico , Enfermedad de Whipple/patología , Antibacterianos/uso terapéutico , Estado Epiléptico/complicaciones
2.
J Alzheimers Dis ; 63(2): 625-633, 2018.
Artículo en Inglés | MEDLINE | ID: mdl-29689726

RESUMEN

BACKGROUND: The contrast between memory versus executive function impairments is commonly used to differentiate between neurocognitive disorders (NCDs) due to Alzheimer's disease (AD) and vascular cognitive impairment (VCI). We reconsidered this question because of the current use of AD biomarkers and the recent revision of the criteria for AD, VCI, and dysexecutive syndrome. OBJECTIVE: To establish and compare the neuropsychological profiles in AD (i.e., with positive CSF biomarkers) and in VCI. METHODS: We included 62 patients with mild or major NCDs due to pure AD (with positive CSF biomarker assays), and 174 patients (from the GRECogVASC cohort) with pure VCI. The neuropsychological profiles were compared after stratification for disease severity (mild or major NCD). We defined a memory-executive function index (the mean z score for the third free recall and the delayed free recall in the Free and Cued Selective Reminding Test minus the mean z score for category fluency and the completion time in the Trail Making Test part B) and determined its diagnostic accuracy. RESULTS: Compared with VCI patients, patients with AD had significantly greater memory impairments (p = 0.001). Executive function was impaired to a similar extent in the two groups (p = 0.11). Behavioral executive disorders were more prominent in the AD group (p = 0.001). Although the two groups differed significant with regard to the memory-executive function index (p < 0.001), the latter's diagnostic accuracy was only moderate (sensitivity: 63%, specificity: 87%). CONCLUSION: Although the contrast between memory and executive function impairments was supported at the group level it does not reliably discriminate between AD and VCI at the individual level.


Asunto(s)
Enfermedad de Alzheimer/diagnóstico , Trastornos Cerebrovasculares/diagnóstico , Disfunción Cognitiva/diagnóstico , Función Ejecutiva , Memoria , Enfermedad de Alzheimer/psicología , Biomarcadores/líquido cefalorraquídeo , Trastornos Cerebrovasculares/psicología , Disfunción Cognitiva/psicología , Estudios de Cohortes , Diagnóstico Diferencial , Humanos , Trastornos de la Memoria/diagnóstico , Trastornos de la Memoria/etiología , Pruebas Neuropsicológicas , Índice de Severidad de la Enfermedad
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA